deltatrials
Active Not Recruiting OBSERVATIONAL NCT02633111

DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas

Sponsor: M.D. Anderson Cancer Center

Updated 22 times since 2017 Last updated: Nov 3, 2025 Started: Oct 31, 2015 Primary completion: Oct 31, 2026 Completion: Oct 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02633111, this observational or N/A phase trial focuses on Aggressive and B-cell Non-Hodgkin Lymphoma and remains ongoing. Sponsored by M.D. Anderson Cancer Center, it has been updated 22 times since 2015, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshot~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshot~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshot~Nov 2018 – ~May 2019 · 6 months · monthly snapshot~May 2019 – ~Aug 2019 · 3 months · monthly snapshot~Aug 2019 – ~Nov 2019 · 3 months · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Apr 2020 · 4 months · monthly snapshot~Apr 2020 – ~Aug 2020 · 4 months · monthly snapshot~Aug 2020 – ~Nov 2020 · 3 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Sep 2022 · 9 months · monthly snapshot~Sep 2022 – ~Apr 2023 · 7 months · monthly snapshot~Apr 2023 – ~Dec 2023 · 8 months · monthly snapshot~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshot~Dec 2024 – ~Dec 2025 · 12 months · monthly snapshot~Dec 2025 – present · 7 months · monthly snapshot

Change History

22 versions recorded
  1. Dec 2025 — Present [monthly]

    Active Not Recruiting

  2. Dec 2024 — Dec 2025 [monthly]

    Active Not Recruiting

  3. Sep 2024 — Dec 2024 [monthly]

    Active Not Recruiting

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting

  5. Dec 2023 — Jul 2024 [monthly]

    Active Not Recruiting

Show 17 earlier versions
  1. Apr 2023 — Dec 2023 [monthly]

    Active Not Recruiting

  2. Sep 2022 — Apr 2023 [monthly]

    Active Not Recruiting

  3. Dec 2021 — Sep 2022 [monthly]

    Active Not Recruiting

  4. Sep 2021 — Dec 2021 [monthly]

    Active Not Recruiting

  5. Jan 2021 — Sep 2021 [monthly]

    Active Not Recruiting

  6. Nov 2020 — Jan 2021 [monthly]

    Active Not Recruiting

  7. Aug 2020 — Nov 2020 [monthly]

    Active Not Recruiting

    Status: RecruitingActive Not Recruiting

  8. Apr 2020 — Aug 2020 [monthly]

    Recruiting

  9. Dec 2019 — Apr 2020 [monthly]

    Recruiting

    Phase: NANone

  10. Nov 2019 — Dec 2019 [monthly]

    Recruiting NA

  11. Aug 2019 — Nov 2019 [monthly]

    Recruiting NA

  12. May 2019 — Aug 2019 [monthly]

    Recruiting NA

  13. Nov 2018 — May 2019 [monthly]

    Recruiting NA

  14. Jun 2018 — Nov 2018 [monthly]

    Recruiting NA

  15. Aug 2017 — Jun 2018 [monthly]

    Recruiting NA

  16. Feb 2017 — Aug 2017 [monthly]

    Recruiting NA

  17. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Oct 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • M.D. Anderson Cancer Center
  • Mayo Clinic
  • Memorial Sloan Kettering Cancer Center
  • University of Miami
  • University of Pennsylvania
Data source: Memorial Sloan Kettering Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .